PTGS2 and cancer: Expectedly, overexpression of COX-2/PGE2 is common in a broad range of human cancers, and it has been implicated in the mechanisms of anti-cell death and immunosuppression through Bcl-2 upregulation and IL-12 downregulation (33–38).